临床药师对降低心血管介入抗菌药物预防使用率的干预作用  

The Antibacterial Chemoprophylaxis Usage for Cardiovascular Intervention Reduced by Clinical Pharmacist’s Intervention

作　　者：陈方[1] 常惠礼[1] 张小勇[2] 麦露丝[1] 李巧汶[2] 蔡嘉利[1] 

机构地区：[1]暨南大学医学院附属清远市人民医院药事管理科,清远511518 [2]暨南大学医学院附属清远市人民医院胸心中心,清远511518

出　　处：《中国医药导刊》2013年第5期824-825,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨临床药师对降低心血管介入抗菌药物预防使用率的干预作用。方法:对比临床药师干预前后我院冠状动脉造影术(CAG)和冠状动脉内支架术(PCI)抗菌药物预防使用率和术后感染情况。结果:通过4个阶段的干预,CAG和PCI抗菌药物预防使用率分别由干预前的86.1%和88.3%下降为0%和1.5%,均有显著差异(P<0.05);干预前后术后感染率均为0%,无统计学差异(P=1)。结论:临床药师干预对降低心血管介入抗菌药物预防使用率效果显著,充分发挥了药学监督作用,促进了抗菌药物的合理使用。Objective：To explore the antibacterial chemoprophylaxis usage for cardiovascular intervention reduced by Clinical pharmacist＇s intervention.Methods：Compared the rates of antibacterial chemoprophylaxis usage and postoperative infection for coronary angiography（CAG） and percutaneous coronary intervention（PCI） before and after the clinical pharmacist’s intervention.Results：After the four stages of intervention,the rates of antibacterial chemoprophylaxis usage for CAG and PCI decreased from 86.1% to 0% and 88.3% to 1.5%.There were significant differences（P0.05）;Before and after the pharmacist’s intervention,the postoperative infection rates were 0%.There was no significant difference（P=1）.Conclusion：The clinical pharmacist＇s intervention played an important role in reducing the antibacterial chemoprophylaxis usage for cardiovascular intervention.They supervised pharmacy to promote the rational usage of antimicrobial agents.

关 键 词：临床药师 心血管介入 抗菌药物 预防使用率 

分 类 号：R951[医药卫生—药学]